Ascent Group, LLC Abbott Laboratories Transaction History

Ascent Group, LLC

$1.29 Billion
Q3 2024

A detailed history of Ascent Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ascent Group, LLC holds 18,156 shares of ABT stock, worth $2.14 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

18,156

Previous 21,772 16.61%

Holding current value

$2.14 Million

Previous $2.26 Million 8.53%

% of portfolio

0.16%

Previous 0.19%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $361,853 - $427,158	-3,616 Reduced 16.61%	18,156 $2.07 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $265,826 - $296,729	2,639 Added 13.79%	21,772 $2.26 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $1.7 Million - $1.88 Million	15,561 Added 435.64%	19,133 $2.17 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $41,848 - $51,225	464 Added 14.93%	3,572 $393,000
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $24,073 - $28,884	-252 Reduced 7.5%	3,108 $301,000
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $92,112 - $102,633	-914 Reduced 21.39%	3,360 $366,000
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $67,705 - $79,692	-699 Reduced 14.06%	4,274 $432,000
Q4 2022 Feb 16, 2023	BUY	$95.06 - $111.52 $67,017 - $78,621	705 Added 16.52%	4,973 $546,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $36,478 - $42,235	-377 Reduced 8.12%	4,268 $422,000
Q2 2022 Aug 05, 2022	BUY	$102.07 - $123.37 $11,125 - $13,447	109 Added 2.4%	4,645 $506,000
Q1 2022 May 10, 2022	SELL	$114.02 - $139.04 $15,164 - $18,492	-133 Reduced 2.85%	4,536 $537,000
Q4 2021 Mar 01, 2022	BUY	$115.53 - $141.46 $539,409 - $660,476	4,669 New	4,669 $588,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.

Account